The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil
Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19. Methods We carried out an analysis of all pediatric patients 2–19 years of...
Saved in:
Published in: | Pediatric pulmonology Vol. 58; no. 3; pp. 727 - 737 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Wiley Subscription Services, Inc
01-03-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Objective
There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19.
Methods
We carried out an analysis of all pediatric patients 2–19 years of age with asthma and COVID‐19 registered in Influenza Epidemiological Surveillance Information System‐Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function.
Results
Among 30,405 hospitalized children with COVID‐19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29–0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in‐hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5–6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4–3.2).
Conclusion
Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors. |
---|---|
AbstractList | There have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID-19.
We carried out an analysis of all pediatric patients 2-19 years of age with asthma and COVID-19 registered in Influenza Epidemiological Surveillance Information System-Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function.
Among 30,405 hospitalized children with COVID-19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29-0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in-hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5-6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4-3.2).
Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors. Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19. Methods We carried out an analysis of all pediatric patients 2–19 years of age with asthma and COVID‐19 registered in Influenza Epidemiological Surveillance Information System‐Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. Results Among 30,405 hospitalized children with COVID‐19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29–0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in‐hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5–6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4–3.2). Conclusion Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors. OBJECTIVEThere have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID-19. METHODSWe carried out an analysis of all pediatric patients 2-19 years of age with asthma and COVID-19 registered in Influenza Epidemiological Surveillance Information System-Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. RESULTSAmong 30,405 hospitalized children with COVID-19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29-0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in-hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5-6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4-3.2). CONCLUSIONChildren with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors. |
Author | Martelli‐Júnior, Hercílio Vasconcelos, Mariana A. Simões e Silva, Ana C. Mak, Robert H. Colosimo, Enrico A. Silva, Ludmila R. Oliveira, Maria C. L. Pinhati, Clara C. Oliveira, Eduardo A. |
Author_xml | – sequence: 1 givenname: Maria C. L. surname: Oliveira fullname: Oliveira, Maria C. L. organization: Federal University of Minas Gerais (UFMG) – sequence: 2 givenname: Enrico A. surname: Colosimo fullname: Colosimo, Enrico A. organization: Federal University of Minas Gerais – sequence: 3 givenname: Mariana A. surname: Vasconcelos fullname: Vasconcelos, Mariana A. organization: Federal University of Minas Gerais (UFMG) – sequence: 4 givenname: Hercílio surname: Martelli‐Júnior fullname: Martelli‐Júnior, Hercílio organization: State University of Montes Claros (Unimontes) – sequence: 5 givenname: Robert H. surname: Mak fullname: Mak, Robert H. organization: University of California, San Diego – sequence: 6 givenname: Ludmila R. surname: Silva fullname: Silva, Ludmila R. organization: Federal University of Minas Gerais (UFMG) – sequence: 7 givenname: Clara C. surname: Pinhati fullname: Pinhati, Clara C. organization: Federal University of Minas Gerais (UFMG) – sequence: 8 givenname: Ana C. surname: Simões e Silva fullname: Simões e Silva, Ana C. organization: Federal University of Minas Gerais (UFMG) – sequence: 9 givenname: Eduardo A. orcidid: 0000-0002-5642-7164 surname: Oliveira fullname: Oliveira, Eduardo A. email: eduolive812@gmail.com organization: Federal University of Minas Gerais (UFMG) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36382503$$D View this record in MEDLINE/PubMed |
BookMark | eNp90c1u1DAUBWALtaLTwoYHQJbYoEpp7Ti24yUd_iqN1C5atpHHviEuiR3sREO76gsg8Yw8CR6mdNEFq7vwd4-vdA7Rng8eEHpFyQklpDwdx7k_KUVZ8WdoQYlSBamU2EOLWnJeiFqwA3SY0g0h-U3R5-iACVaXnLAF-nnVAdYpBeP05ILHa5g2AB6PEX7f_4IfLk3Of81k6gaNtbc4gp0N5OnSNxxabEFPHdZDyMx0rrcxr2-htqGHZMBPCXchjW7SvbvLmxuXF5YXX87f5y-ows7js6jvXP8C7be6T_DyYR6h648frpafi9XFp_Plu1VhGJe8oKw1ylij2lZxUhJZGSoqLhXVa0rAKlVSSzkXXLQls1CVVldGMVMrIypg7Ai93eWOMXyfIU3N4PKhfa89hDk1pWSS0ppSmembJ_QmzNHn67KSQomKSJrV8U6ZGFKK0DZjdIOOtw0lzbakZltS87ekjF8_RM7rAewj_ddKBnQHNq6H2_9ENZeX16td6B-jV6Ds |
CitedBy_id | crossref_primary_10_3389_fimmu_2023_1217181 crossref_primary_10_1093_jpids_piae052 |
Cites_doi | 10.1016/j.jaci.2020.08.008 10.1080/02770903.2021.1888116 10.1002/ppul.24909 10.1111/cea.14021 10.1016/j.jaci.2020.04.061 10.1097/INF.0000000000003043 10.1186/s12948-021-00159-4 10.1016/S2213-2600(21)00491-4 10.1542/peds.2021-056164 10.1080/01621459.1999.10474144 10.1007/s00467-022-05588-0 10.1183/13993003.02226-2020 10.1111/all.14426 10.1007/s00408-021-00419-9 10.1002/ppul.26132 10.1002/ppul.25937 10.1111/pai.13696 10.1038/s41586-020-2521-4 10.1002/ppul.25117 10.1111/ijpo.12920 10.1016/j.jpeds.2022.01.001 10.1002/ppul.26091 10.1016/j.anai.2020.07.029 10.1016/j.anai.2022.03.017 10.1136/thoraxjnl-2021-218629 10.1016/S2352-4642(21)00277-7 10.1002/ppul.26065 10.1016/j.jpeds.2022.02.048 10.1111/pedi.13335 10.1111/all.14480 10.1016/j.ccc.2021.05.003 10.1159/000518896 10.1016/S2352-4642(21)00134-6 10.1002/sim.2712 10.3389/fimmu.2022.705379 10.1016/j.resinv.2019.12.005 10.1590/S0021-75572006000600006 10.1002/ppul.26184 10.1542/peds.2021-055765 10.1016/j.pcl.2021.05.012 |
ContentType | Journal Article |
Copyright | 2022 Wiley Periodicals LLC. 2023 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2022 Wiley Periodicals LLC. – notice: 2023 Wiley Periodicals LLC. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. 7X8 |
DOI | 10.1002/ppul.26245 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1099-0496 |
EndPage | 737 |
ExternalDocumentID | 10_1002_ppul_26245 36382503 PPUL26245 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Brazil |
GeographicLocations_xml | – name: Brazil |
GrantInformation_xml | – fundername: Conselho Nacional de Desenvolvimento Científico e Tecnológico – fundername: Fundação de Amparo à Pesquisa do Estado de Minas Gerais |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c3575-13fc9cdc9ff9502074c1645791ab10ed9921d155656f23de42da4c93c89c64e33 |
IEDL.DBID | 33P |
ISSN | 8755-6863 |
IngestDate | Fri Aug 16 04:43:30 EDT 2024 Thu Oct 10 20:42:08 EDT 2024 Thu Nov 21 21:36:55 EST 2024 Sat Sep 28 08:15:36 EDT 2024 Sat Aug 24 01:12:04 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | COVID-19 SARS-CoV-2 risk factors asthma children outcome |
Language | English |
License | 2022 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3575-13fc9cdc9ff9502074c1645791ab10ed9921d155656f23de42da4c93c89c64e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5642-7164 |
PMID | 36382503 |
PQID | 2776964071 |
PQPubID | 1036356 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2737118117 proquest_journals_2776964071 crossref_primary_10_1002_ppul_26245 pubmed_primary_36382503 wiley_primary_10_1002_ppul_26245_PPUL26245 |
PublicationCentury | 2000 |
PublicationDate | March 2023 2023-03-00 20230301 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: March 2023 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Pediatric pulmonology |
PublicationTitleAlternate | Pediatr Pulmonol |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 68 2021; 5 2022; 23 2020; 58 2020; 584 2020; 55 2020; 146 2020; 125 2021; 57 2022; 101 2022; 244 2006; 82 2021; 59 2021; 37 2021; 76 2022 2021; 19 2022; 57 2022; 13 2022; 52 2022; 10 2021; 199 1999; 94 2022; 33 2022; 129 2021; 40 2022; 149 2022; 17 2022; 245 2007; 26 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_20_1 e_1_2_9_40_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – volume: 68 start-page: 1119 issue: 5 year: 2021 end-page: 1131 article-title: The impact of coronavirus disease 2019 on pediatric asthma in the United States publication-title: Pediatr Clin North Am – volume: 10 start-page: 191 issue: 2 year: 2022 end-page: 198 article-title: Risk of COVID‐19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study publication-title: Lancet Resp Med – volume: 94 start-page: 496 year: 1999 end-page: 509 article-title: A proportional hazards model for the sub‐distribution of a competing risk publication-title: J Am Stat Assoc – volume: 146 start-page: 334 issue: 2 year: 2020 end-page: 335 article-title: Prevalence of comorbid asthma in COVID‐19 patients publication-title: J Allergy Clin Immunol – volume: 584 start-page: 430 issue: 7821 year: 2020 end-page: 436 article-title: Factors associated with COVID‐19‐related death using OpenSAFELY publication-title: Nature – volume: 5 start-page: e40 issue: 10 year: 2021 end-page: e42 article-title: Risk factors for COVID‐19 mortality in hospitalised children and adolescents in Brazil—authors' reply publication-title: Lancet Child Adolescent Health – volume: 199 start-page: 7 issue: 1 year: 2021 end-page: 12 article-title: COVID‐19 in children with asthma publication-title: Lung – year: 2022 article-title: Asthma as a comorbidity in COVID‐19 pediatric ICU admissions in a large metropolitan children's hospital publication-title: Pediatr Pulmonol – volume: 5 start-page: 559 issue: 8 year: 2021 end-page: 568 article-title: Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID‐19 in Brazil: an analysis of a nationwide database publication-title: Lancet Child Adolescent Health – volume: 52 start-page: 7 issue: 1 year: 2022 end-page: 9 article-title: Hypotheses to explain the associations between asthma and the consequences of COVID‐19 infection publication-title: Clin Exp Allergy – volume: 76 start-page: 866 issue: 3 year: 2021 end-page: 868 article-title: Is asthma protective against COVID‐19 publication-title: Allergy – volume: 58 start-page: 155 issue: 3 year: 2020 end-page: 168 article-title: Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV‐229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells publication-title: Resp Investig – volume: 55 start-page: 2412 issue: 9 year: 2020 end-page: 2418 article-title: Asthma and COVID‐19 in children: a systematic review and call for data publication-title: Pediatr Pulmonol – volume: 57 start-page: 3044 issue: 12 year: 2022 end-page: 3049 article-title: Clinical presentation and outcomes of hospitalized children with COVID‐19 in Mexico City publication-title: Pediatr Pulmonol – volume: 19 start-page: 19 issue: 1 year: 2021 article-title: The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID‐19 publication-title: Clin Mol Allergy – volume: 245 start-page: 102 year: 2022 end-page: 110 article-title: Comorbidities associated with hospitalization and progression among adolescents with symptomatic coronavirus disease 2019 publication-title: J Pediatr – volume: 23 start-page: 763 issue: 6 year: 2022 end-page: 772 article-title: Risk factors for COVID‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: an observational retrospective cohort study publication-title: Pediatr Diabetes – volume: 33 issue: 1 year: 2022 article-title: Asthma as a risk factor for hospitalization in children with COVID‐19: a nested case‐control study publication-title: Pediatr Allergy Immunol – volume: 40 start-page: e137 issue: 4 year: 2021 end-page: e145 article-title: Risk factors for severe COVID‐19 in children publication-title: Pediatr Infect Dis J – volume: 55 start-page: 3573 issue: 12 year: 2020 end-page: 3578 article-title: Pediatric asthma and COVID‐19: the known, the unknown, and the controversial publication-title: Pediatr Pulmonol – volume: 57 start-page: 1693 issue: 7 year: 2022 end-page: 1700 article-title: Comparison of clinical features of COVID‐19 infection in children with asthma and their healthy peers publication-title: Pediatr Pulmonol – volume: 17 issue: 9 year: 2022 article-title: Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID‐19 in Brazil: an analysis of a nationwide database publication-title: Pediatr Obes – volume: 76 start-page: 565 issue: 2 year: 2021 end-page: 567 article-title: COVID‐19 and asthma, the good or the bad? publication-title: Allergy – volume: 101 start-page: 307 issue: 3 year: 2022 end-page: 320 article-title: Risk assessment for patients with chronic respiratory conditions in the context of the SARS‐CoV‐2 pandemic statement of the German respiratory society with the support of the German association of chest physicians publication-title: Respiration – volume: 59 start-page: 866 year: 2021 end-page: 879 article-title: Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID‐19: systematic review and meta‐analysis publication-title: J Asthma – volume: 149 issue: 6 year: 2022 article-title: Asthma and the risk of SARS‐CoV‐2 infection among children and adolescents publication-title: Pediatrics – volume: 129 start-page: 79 issue: 1 year: 2022 end-page: 87 article-title: Asthma and coronavirus disease 2019–related outcomes in hospitalized patients publication-title: Ann Allergy Asthma Immunol – volume: 125 start-page: 707 issue: 6 year: 2020 end-page: 709 article-title: Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia publication-title: Ann Allergy Asthma Immunol – volume: 13 year: 2022 article-title: Causal association and shared genetics between asthma and COVID‐19 publication-title: Front Immunol – volume: 146 start-page: 790 issue: 4 year: 2020 end-page: 798 article-title: Allergic disorders and susceptibility to and severity of COVID‐19: a nationwide cohort study publication-title: J Allergy Clin Immunol – volume: 37 start-page: 749 issue: 4 year: 2021 end-page: 776 article-title: Pathophysiology of acute respiratory distress syndrome and COVID‐19 lung injury publication-title: Crit Care Clin – year: 2022 article-title: Relationship between asthma and severe COVID‐19: a national cohort study publication-title: Thorax – volume: 149 issue: 4 year: 2022 article-title: Severity of acute COVID‐19 in children <18 years old March 2020 to December 2021 publication-title: Pediatrics – volume: 82 start-page: 341 issue: 5 year: 2006 end-page: 346 article-title: Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the international study of asthma and allergies in childhood (ISAAC)—phase 3 publication-title: J Pediatr – volume: 244 start-page: 178 year: 2022 end-page: 185 article-title: Comparison of the first and second waves of the coronavirus disease 2019 pandemic in children and adolescents in a Middle‐Income country: clinical impact associated with severe acute respiratory syndrome coronavirus 2 gamma lineage publication-title: J Pediatr – volume: 26 start-page: 2389 issue: 11 year: 2007 end-page: 2430 article-title: Tutorial in biostatistics: competing risks and multi‐state models publication-title: Stat Med – volume: 57 start-page: 2491 year: 2022 end-page: 2501 article-title: The prevalence and associated factors of asthma, allergic rhinitis, and eczema in Turkish children and adolescents publication-title: Pediatr Pulmonol – volume: 57 issue: 3 year: 2021 article-title: Effect of asthma and asthma medication on the prognosis of patients with COVID‐19 publication-title: Eur Respir J – volume: 57 start-page: 2855 issue: 11 year: 2022 end-page: 2860 article-title: Asthma 17q21 polymorphism associates with decreased risk of COVID‐19 in children publication-title: Pediatr Pulmonol – year: 2022 article-title: Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID‐19: an analysis of a nationwide database publication-title: Pediatr Nephrol – ident: e_1_2_9_7_1 doi: 10.1016/j.jaci.2020.08.008 – ident: e_1_2_9_8_1 doi: 10.1080/02770903.2021.1888116 – ident: e_1_2_9_18_1 doi: 10.1002/ppul.24909 – ident: e_1_2_9_31_1 doi: 10.1111/cea.14021 – ident: e_1_2_9_38_1 doi: 10.1016/j.jaci.2020.04.061 – ident: e_1_2_9_29_1 doi: 10.1097/INF.0000000000003043 – ident: e_1_2_9_37_1 doi: 10.1186/s12948-021-00159-4 – ident: e_1_2_9_16_1 doi: 10.1016/S2213-2600(21)00491-4 – ident: e_1_2_9_17_1 doi: 10.1542/peds.2021-056164 – ident: e_1_2_9_23_1 doi: 10.1080/01621459.1999.10474144 – ident: e_1_2_9_27_1 doi: 10.1007/s00467-022-05588-0 – ident: e_1_2_9_6_1 doi: 10.1183/13993003.02226-2020 – ident: e_1_2_9_32_1 doi: 10.1111/all.14426 – ident: e_1_2_9_39_1 doi: 10.1007/s00408-021-00419-9 – ident: e_1_2_9_24_1 doi: 10.1002/ppul.26132 – ident: e_1_2_9_14_1 doi: 10.1002/ppul.25937 – ident: e_1_2_9_28_1 doi: 10.1111/pai.13696 – ident: e_1_2_9_3_1 doi: 10.1038/s41586-020-2521-4 – ident: e_1_2_9_5_1 doi: 10.1002/ppul.25117 – ident: e_1_2_9_26_1 doi: 10.1111/ijpo.12920 – ident: e_1_2_9_20_1 doi: 10.1016/j.jpeds.2022.01.001 – ident: e_1_2_9_34_1 doi: 10.1002/ppul.26091 – ident: e_1_2_9_12_1 doi: 10.1016/j.anai.2020.07.029 – ident: e_1_2_9_10_1 doi: 10.1016/j.anai.2022.03.017 – ident: e_1_2_9_11_1 doi: 10.1136/thoraxjnl-2021-218629 – ident: e_1_2_9_19_1 doi: 10.1016/S2352-4642(21)00277-7 – ident: e_1_2_9_15_1 doi: 10.1002/ppul.26065 – ident: e_1_2_9_4_1 doi: 10.1016/j.jpeds.2022.02.048 – ident: e_1_2_9_25_1 doi: 10.1111/pedi.13335 – ident: e_1_2_9_35_1 doi: 10.1111/all.14480 – ident: e_1_2_9_40_1 doi: 10.1016/j.ccc.2021.05.003 – ident: e_1_2_9_13_1 doi: 10.1159/000518896 – ident: e_1_2_9_21_1 doi: 10.1016/S2352-4642(21)00134-6 – ident: e_1_2_9_22_1 doi: 10.1002/sim.2712 – ident: e_1_2_9_33_1 doi: 10.3389/fimmu.2022.705379 – ident: e_1_2_9_36_1 doi: 10.1016/j.resinv.2019.12.005 – ident: e_1_2_9_41_1 doi: 10.1590/S0021-75572006000600006 – ident: e_1_2_9_9_1 doi: 10.1002/ppul.26184 – ident: e_1_2_9_30_1 doi: 10.1542/peds.2021-055765 – ident: e_1_2_9_2_1 doi: 10.1016/j.pcl.2021.05.012 |
SSID | ssj0009991 |
Score | 2.4386191 |
Snippet | Objective
There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among... There have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with... ObjectiveThere have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among... OBJECTIVEThere have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 727 |
SubjectTerms | Adolescent Asthma Asthma - epidemiology Brazil - epidemiology Child children Comorbidity COVID-19 COVID-19 - epidemiology Hospitalization Humans outcome risk factors SARS-CoV-2 |
Title | The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26245 https://www.ncbi.nlm.nih.gov/pubmed/36382503 https://www.proquest.com/docview/2776964071 https://search.proquest.com/docview/2737118117 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA7ag3hxX-pGRE_CaCfJZCbgxRUFl4IL3oZMFlrUaWntpSf_gOBv9Jf4kpm2iiCIpwnMCwl5eXlflvc9hLZrxhqWhDaQkVIB40QEGewaAg3eHLxJknGfi-DsJr56SI5PHE3O_iAWpuCHGB64Ocvw67UzcJl190akoe1272mXcMJchDlsE3z8Bq2PGHeFT5cHeDwKeMLpkJuU7I2qfvdGPyDmd8TqXc7p9P86O4OmSqiJD4q5MYvGTD6HJi7Ly_R59AZTBMuRenD5Zgu3O-bj9d1xZLo30SDy0niWWOYadxzRq4Fvs_uIWxZrByCxT1iEB2HhXvALURRulKlJmn2o6c598dH1_fkxNBEK3MzxYUf2m08L6O705PboLCizMwSKAsYLQmqVUFoJa0UEoDNmCrZeUSxCmYU1o4UgoQa0AoDREqoNI1oyJahKhOLMULqIKnkrN8sIRyKxmmtKGYuYqWUZ1wZwodTCypphtIq2BlpK2wUJR1rQLZPUjWzqR7aK1gYKTEtD7KYkjrlwl5VhFW0Of4MJuXsRmZtWz8nQ2MXfhnEVLRWKHzZDYX0ClAhd2PH6_aX9tF6_u_Cllb8Ir6JJl8K-eNe2hiovnZ5ZR-Nd3dvwE_oTKp_6Qw |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB7RIlEu5VVoSilG5YS0Tdb2etcHDpC2SkRaIrVF3FZeP5SIdBMlzaUn_gBSf2N_CWPvJqFCQqo47Uo7lleeGc_nx3wD8L5lneVZ7CKVaB1xQWVU4KohMhjNMZpkhQi1CDpn6en37PDI0-R8XOTCVPwQyw037xlhvvYO7jekmyvW0MlkPjqggvJkDR5ygZboMzhYf8W5K0PBPETkSSQywZbspLS5ans3Hv0FMu9i1hB0jp_85-8-hc0abZJPlXk8gwe2fA6PTurz9BfwC62EqJWGSH1ti0ym9vbnjafJ9NeiUeRqcKmIKg2Zeq5Xi8_h7AcZO2I8hiShZhFZZIYHwT-4osigrk4yvMaWfuuXtL9-6x5iF7Ekw5J8nqrr4WgLLo6PztudqC7QEGmGMC-KmdNSGy2dkwnizpRrXH0lqYxVEbeskZLGBgELYkZHmbGcGsW1ZDqTWnDL2EtYL8el3QaSyMwZYRjjPOG2VRTCWISGykinWpazBuwv1JRPKh6OvGJcprkf2TyMbAN2FxrMa1-c5TRNhfTnlXED3i0_oxf5oxFV2vHcy7DUp-DGaQNeVZpfdsNwikKgiL_wISj4H_3n_f5FL7zt3Ef4LWx0zk96ea97-uU1PPYV7atrbruwfjWd2zewNjPzvWDdvwHr6f5r |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bSxwxFD54AemL1l50vTWlfSqM7iSZzAT60rouSq1dUItvQyYXXNTZYdd98ck_UOhv9Jd4kpndVQqF0qcJzAkJOTk5X3KS7wB8bFtneRa7SCVaR1xQGRW4a4gMenP0JlkhQi6Cw9P05CLrHHianM-TtzA1P8T0wM1bRlivvYFXxu3NSEOrany9SwXlyTwscsThnjmfsd6McleGfHkIyJNIZIJNyUnp3qzuc3f0B8Z8DlmDz-mu_F9vX8JygzXJl3pyrMKcLV_B0vcmmv4afuEcIWqmH9Jc2iLV0D7c__Ykmf5SNIrcXt4ookpDhp7p1eK3P7oiA0eMR5AkZCwik3fhQfAJUxS5bHKT9O-wpj_4Jfs_fh51sIlYkn5Jvg7VXf_6DZx3D872D6MmPUOkGYK8KGZOS220dE4miDpTrnHvlaQyVkXctkZKGhuEK4gYHWXGcmoU15LpTGrBLWNvYaEclHYdSCIzZ4RhjPOE23ZRCGMRGCojnWpbzlrwYaKlvKpZOPKab5nmfmTzMLIt2JooMG8scZTTNBXSRyvjFryf_kYb8oERVdrB2Muw1D_AjdMWrNWKnzbDcIFCmIhd-BT0-5f2817v_DiUNv5F-B0s9Trd_Pjo5NsmvPDp7Os7bluwcDsc222YH5nxTpjbj96b_RE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+pre%E2%80%90existing+asthma+and+reduced+risk+of+death+among+children+and+adolescents+hospitalized+with+COVID%E2%80%9019+in+Brazil&rft.jtitle=Pediatric+pulmonology&rft.au=Oliveira%2C+Maria+C.+L.&rft.au=Colosimo%2C+Enrico+A.&rft.au=Vasconcelos%2C+Mariana+A.&rft.au=Martelli%E2%80%90J%C3%BAnior%2C+Herc%C3%ADlio&rft.date=2023-03-01&rft.issn=8755-6863&rft.eissn=1099-0496&rft.volume=58&rft.issue=3&rft.spage=727&rft.epage=737&rft_id=info:doi/10.1002%2Fppul.26245&rft.externalDBID=10.1002%252Fppul.26245&rft.externalDocID=PPUL26245 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8755-6863&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8755-6863&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8755-6863&client=summon |